Chitogen


Chitogen Inc. is a medical device company dedicated to developing next-generation proprietary hemostatic products for controlling severe bleeding. Their products are designed for a wide range of applications including surgical, cardiovascular, dialysis, trauma, and military environments, focusing on non-absorbable topical solutions that promote rapid and safe hemostasis.

Industries

hardware
health-care
intrusion-detection
manufacturing
medical-device

Nr. of Employees

small (1-50)

Chitogen

Plymouth, Minnesota, United States, North America


Products

Topical chitosan hemostatic pad for femoral access

Sterile topical hemostatic pad made from surface-treated chitosan fiber fleece intended to control bleeding at femoral vascular access sites and reduce compression time.

Topical chitosan hemostatic pad for radial access

Sterile chitosan-based hemostatic pad configured for radial access sites and intended for use with compression bands to reduce radial hold time and promote patent hemostasis.

Dialysis hemostatic pads (two pads per pouch)

Sterile pouches each containing two small topical chitosan hemostatic pads designed to reduce hold times and pressure on dialysis fistulae during post-dialysis hemostasis.

Duplex hemostatic dressing for trauma (developmental)

A dual-component hemostatic dressing combining surface-treated chitosan fiber with a hydrophilic polymer powder intended for severe/traumatic hemorrhage; currently undergoing field testing and preclinical evaluation.


Services

Direct product sales and ordering

Online order intake and processing for sterile topical hemostatic pads and dialysis pouch products with billing and shipping address collection.

Clinical and technical information support

Provision of clinical application instructions, IFUs, white papers and trial data to support clinical adoption and user training.

Expertise Areas

  • Topical hemostatic device development
  • Chitosan biomaterials and surface chemistry
  • Interventional cardiology and vascular access hemostasis
  • Dialysis vascular access hemostasis
  • Show More (5)

Key Technologies

  • Chitosan-based hemostatic fibers
  • Surface treatment to modify ionic charge/pH
  • Nonwoven fiber fleece fabrication
  • Duplex hemostatic dressing (fiber + hydrophilic polymer powder)
  • Show More (2)

Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.